{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:22:52Z","timestamp":1791912172467,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,6]],"date-time":"2027-05-06T00:00:00Z","timestamp":1809561600000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002894","name":"AAAAI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002894","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1UG3AI190386"],"award-info":[{"award-number":["1UG3AI190386"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jaip.2026.02.008","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:39:58Z","timestamp":1778060398000},"page":"1034-1047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Redefining Diagnostic and Management Approaches to Vancomycin Adverse Drug Reactions"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4110-7221","authenticated-orcid":false,"given":"Santiago","family":"Alvarez-Arango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Konvinse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaswini","family":"Pujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid P.","family":"Salciccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Bland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","article-title":"Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012","volume":"176","author":"Baggs","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2026.02.008_bib2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2146\/ajhp060651","article-title":"Observations on vancomycin use in U.S. hospitals","volume":"64","author":"Paladino","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaip.2026.02.008_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaip.2026.02.008_bib4","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jaip.2026.02.008_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2015.03.011","article-title":"Review of meta-analyses of vancomycin compared with new treatments for gram-positive skin and soft-tissue infections: are we any clearer?","volume":"46","author":"Tsoulas","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jaip.2026.02.008_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2026.02.008_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0140-6736(78)91741-5","article-title":"Oral vancomycin for antibiotic-associated pseudomembranous colitis","volume":"312","author":"Tedesco","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.02.008_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/00365548.2010.544671","article-title":"Systemic absorption of oral vancomycin in patients with Clostridium difficile infection","volume":"43","author":"Rao","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/23.1.167","article-title":"Comparison of two oral formulations of vancomycin for treatment of diarrhoea associated with Clostridium difficile","volume":"23","author":"Baird","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2026.02.008_bib10","series-title":"Vancomycin. StatPearls","author":"Patel","year":"2025"},{"key":"10.1016\/j.jaip.2026.02.008_bib11","series-title":"Preoperative antibiotic prophylaxis. StatPearls","author":"Crader","year":"2025"},{"key":"10.1016\/j.jaip.2026.02.008_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jor.2024.03.040","article-title":"Local vancomycin administration in orthopaedic surgery - a systematic review of comparative studies","volume":"55","author":"Lameire","year":"2024","journal-title":"J Orthop"},{"key":"10.1016\/j.jaip.2026.02.008_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/idr15020019","article-title":"A case of oral-vancomycin-induced rash in a patient with acute kidney injury","volume":"15","author":"Cardozo","year":"2023","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.jaip.2026.02.008_bib14","article-title":"Drug reaction with eosinophilia and systemic symptoms to vancomycin-laden cement space: a case report","volume":"17","author":"Chalasani","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2026.02.008_bib15","first-page":"61","article-title":"Allergic reaction following insertion of vancomycin loaded in bone cement","volume":"13","author":"Goh","year":"2014","journal-title":"Int Med J Malays"},{"key":"10.1016\/j.jaip.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/crsi.2016.0023","article-title":"Local inflammatory reaction to vancomycin-laden bone cement","volume":"1","author":"Young","year":"2016","journal-title":"Surgical Infect Case Rep"},{"key":"10.1016\/j.jaip.2026.02.008_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.krcp.2014.09.005","article-title":"Immunoglobulin E-mediated hypersensitivity reaction after intraperitoneal administration of vancomycin","volume":"34","author":"Hwang","year":"2015","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3747\/pdi.2010.00062","article-title":"Vancomycin-related eosinophilic peritonitis","volume":"30","author":"Rosner","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.jaip.2026.02.008_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5414\/CN110400","article-title":"Severe eosinophilic peritonitis caused by intraperitoneal vancomycin administration","volume":"96","author":"Hsu","year":"2021","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jaip.2026.02.008_bib20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaip.2020.09.027","article-title":"Vancomycin hypersensitivity reactions documented in electronic health records","volume":"9","author":"Alvarez-Arango","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMp2031891","article-title":"Vancomycin infusion reaction - moving beyond \"red man syndrome.\"","volume":"384","author":"Alvarez-Arango","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.008_bib22","first-page":"402","article-title":"Vancomycin anaphylaxis and successful desensitization","volume":"73","author":"Anne","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2026.02.008_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1081-1206(10)62416-7","article-title":"Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels","volume":"84","author":"Chopra","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00045391-200007050-00010","article-title":"Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome","volume":"7","author":"Hassaballa","year":"2000","journal-title":"Am J Ther"},{"key":"10.1016\/j.jaip.2026.02.008_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.anai.2016.03.030","article-title":"Immune-mediated reactions to vancomycin: a systematic case review and analysis","volume":"116","author":"Minhas","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2019.02.002","article-title":"Vancomycin-associated drug-induced hypersensitivity syndrome","volume":"81","author":"Madigan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2026.02.008_bib27","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/jcm14030930","article-title":"Vancomycin drug reaction with eosinophilia and systemic symptoms: meta-analysis and pharmacovigilance study","volume":"14","author":"Aboukaoud","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaip.2026.02.008_bib28","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1056\/NEJMra2204547","article-title":"Drug reaction with eosinophilia and systemic symptoms","volume":"391","author":"Kroshinsky","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.008_bib29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jaip.2024.02.019","article-title":"Non-IgE-mediated immediate drug-induced hypersensitivity reactions","volume":"12","author":"Alvarez-Arango","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/cc1871","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam","year":"2003","journal-title":"Crit Care"},{"key":"10.1016\/j.jaip.2026.02.008_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0b013e31824e10d7","article-title":"Defining risk factors for red man syndrome in children and adults","volume":"31","author":"Myers","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaip.2026.02.008_bib32","article-title":"Evaluation of immediate vancomycin-induced hypersensitivity reaction to severe perioperative anaphylaxis","volume":"4","author":"Gansert","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2026.02.008_bib33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/AAC.34.4.550","article-title":"Vancomycin-induced histamine release and \"red man syndrome\": comparison of 1- and 2-hour infusions","volume":"34","author":"Healy","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2026.02.008_bib34","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.jaip.2024.07.028","article-title":"A skin testing strategy for non-IgE-mediated reactions associated with vancomycin","volume":"12","author":"Lyu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2026.02.008_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00228-012-1376-5","article-title":"Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority","volume":"69","author":"Ribeiro-Vaz","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: in vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1398-9995.2008.01924.x","article-title":"Update on the evaluation of hypersensitivity reactions to betalactams","volume":"64","author":"Blanca","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.02.008_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2026.02.008_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaip.2022.12.014","article-title":"Allergenic and Mas-related G protein-coupled receptor X2-activating properties of drugs: resolving the two","volume":"11","author":"Sabato","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The pathophysiology of anaphylaxis","volume":"140","author":"Reber","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89362","article-title":"Dual action of neurokinin-1 antagonists on Mas-related GPCRs","volume":"1","author":"Azimi","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2026.02.008_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41586-021-04077-y","article-title":"Structure, function and pharmacology of human itch receptor complexes","volume":"600","author":"Yang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2026.02.008_bib45","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41586-021-04126-6","article-title":"Structure, function and pharmacology of human itch GPCRs","volume":"600","author":"Cao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2026.02.008_bib46","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/cea.13850","article-title":"Vancomycin immediate skin responses in vancomycin-na\u00efve subjects","volume":"51","author":"Alvarez-Arango","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.02.008_bib47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/cea.70068","article-title":"Variants of the MRGPRX2 gene found in patients with hypersensitivity to quinolones and vancomycin show amplified and drug-specific activation responses in vitro","volume":"55","author":"Quan","year":"2025","journal-title":"Clin Exp Allergy"},{"issue":"suppl 9","key":"10.1016\/j.jaip.2026.02.008_bib48","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jen.2011.09.010","article-title":"Allergic reaction or adverse drug effect: correctly classifying vancomycin-induced hypersensitivity reactions","volume":"38","author":"McAuley","year":"2012","journal-title":"J Emerg Nurs"},{"key":"10.1016\/j.jaip.2026.02.008_bib50","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaip.2015.06.017","article-title":"A role for vancomycin epicutaneous skin testing in the evaluation of perioperative anaphylaxis","volume":"3","author":"Otani","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2024.12.1002","article-title":"Immunogenic profiling of vancomycin: detecting vancomycin-specific IgG in patients with and without vancomycin infusion reactions","volume":"155","author":"Arango","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688930","article-title":"Antibody or anybody? Considering the role of MRGPRX2 in acute drug-induced anaphylaxis and as a therapeutic target","volume":"12","author":"Mackay","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib53","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1111\/bcp.15845","article-title":"MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE\/Fc\u03b5RI-mediated events","volume":"89","author":"Baldo","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib54","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/all.13236","article-title":"Immediate moxifloxacin hypersensitivity: is there more than currently meets the eye?","volume":"72","author":"Van Gasse","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.02.008_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bja.2023.05.002","article-title":"Suspected perioperative anaphylaxis: are we making the correct diagnosis?","volume":"131","author":"Ebo","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2026.02.008_bib56","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI85538","article-title":"Different activation signals induce distinct mast cell degranulation strategies","volume":"126","author":"Gaudenzio","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaip.2026.02.008_bib57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib58","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2013an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.02.008_bib59","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.37.10.2139","article-title":"Vancomycin skin tests and prediction of \"red man syndrome\" in healthy volunteers","volume":"37","author":"Polk","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2026.02.008_bib60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics","volume":"112","author":"Empedrad","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib61","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/all.15957","article-title":"Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper","volume":"79","author":"Mayorga","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.02.008_bib62","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib63","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cod.13351","article-title":"Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption","volume":"81","author":"Ben Fadhel","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2026.02.008_bib64","first-page":"1289","article-title":"Fixed drug eruptions - the common and novel culprits since 2000","volume":"20","author":"McClatchy","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2026.02.008_bib65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000063891","article-title":"Fixed drug eruption: easily overlooked but needing new respect","volume":"205","author":"Shiohara","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2026.02.008_bib66","article-title":"Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycin","volume":"4","author":"Mukherjee","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2026.02.008_bib67","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.12502","article-title":"Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients","volume":"169","author":"Hotz","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2026.02.008_bib68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamadermatol.2021.5390","article-title":"Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US","volume":"158","author":"Creadore","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2026.02.008_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40560-015-0114-3","article-title":"Vancomycin-induced acute generalized exanthematous pustulosis (AGEP) masquerading septic shock-an unusual presentation of a rare disease","volume":"3","author":"Mawri","year":"2015","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jaip.2026.02.008_bib70","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/ijms17081214","article-title":"Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy","volume":"17","author":"Feldmeyer","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2026.02.008_bib71","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/cid\/ciac798","article-title":"A shorter time to drug reaction with eosinophilia and systemic symptoms (DRESS): redefining beta-lactam-associated DRESS","volume":"76","author":"Waldron","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.008_bib72","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaad.2023.05.067","article-title":"Drug reaction eosinophilia and systemic symptoms: clinical phenotypic patterns according to causative drug","volume":"90","author":"Blumenthal","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2026.02.008_bib73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib74","article-title":"Associations of HLA-A and HLA-B with vancomycin-induced drug reaction with eosinophilia and systemic symptoms in the Han-Chinese population","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.21911\/aai.511","article-title":"Symptoms and awareness of latex allergy among healthcare workers","volume":"18","author":"Kartal","year":"2020","journal-title":"Asthma Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2022.08.747","article-title":"Hla-a\u221732:01 associated vancomycin-induced Dress syndrome and desquamation in an African American woman","volume":"129","author":"Jalali","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.008_bib77","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jamadermatol.2022.3541","article-title":"Risk factors for vancomycin drug reaction with eosinophilia and systemic symptoms syndrome","volume":"158","author":"Blumenthal","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2026.02.008_bib78","doi-asserted-by":"crossref","DOI":"10.1177\/00185787251341739","article-title":"Vancomycin-induced DRESS syndrome: a systematic review of case reports","author":"Bhumireddy","year":"2025","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.jaip.2026.02.008_bib79","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jamadermatol.2021.3154","article-title":"Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a pan-European multicenter study","volume":"157","author":"Kridin","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2026.02.008_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.872854","article-title":"Stevens-Johnson syndrome following vancomycin and linezolid: a real-world analysis of post-marketing surveillance data","volume":"13","author":"Ni","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib81","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QCO.0000000000000323","article-title":"Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity","volume":"29","author":"Konvinse","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.008_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.573573","article-title":"An updated review of the diagnostic methods in delayed drug hypersensitivity","volume":"11","author":"Copaescu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib83","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/toxsci\/kfaf074","article-title":"Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS","volume":"206","author":"Gardner","year":"2025","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaip.2026.02.008_bib84","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","article-title":"The combined utility of ex vivo IFN-\u03b3 release enzyme-linked ImmunoSpot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions","volume":"6","author":"Trubiano","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.008_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.959321","article-title":"LTT and HLA testing as diagnostic tools in Spanish vancomycin-induced DRESS cases: a case-control study","volume":"13","author":"Bell\u00f3n","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib86","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2215\/CJN.05920616","article-title":"Vancomycin and the risk of AKI: a systematic review and meta-analysis","volume":"11","author":"Sinha Ray","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jaip.2026.02.008_bib87","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40121-019-00278-1","article-title":"A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections","volume":"9","author":"Jorgensen","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jaip.2026.02.008_bib88","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1111\/bcp.15429","article-title":"Risk factors for vancomycin-associated acute kidney injury: a systematic review and meta-analysis","volume":"88","author":"Kim","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284223","article-title":"The influence of vancomycin on renal functions, the predictors and associated factors for nephrotoxicity","volume":"18","author":"Altowayan","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2026.02.008_bib90","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2026.02.008_bib91","first-page":"576","article-title":"Clinical characteristics and treatment outcomes of linear IgA bullous dermatosis","volume":"23","author":"Mar","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2026.02.008_bib92","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/DAD.0000000000003023","article-title":"Vancomycin-induced linear IgA bullous dermatosis mimicking Stevens-Johnson syndrome associated with anticancer therapy","volume":"47","author":"Haymete","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaip.2026.02.008_bib93","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2026.02.008_bib94","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1017\/ice.2020.1229","article-title":"The impact of antibiotic allergy labels on antibiotic exposure, clinical outcomes, and healthcare costs: a systematic review","volume":"42","author":"Krah","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jaip.2026.02.008_bib95","article-title":"The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections","volume":"8","author":"Fu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2026.02.008_bib96","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1060028017735629","article-title":"Rate and incidence of adverse reactions associated with ceftaroline exposure: importance of cutaneous manifestations","volume":"52","author":"Jansen","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2026.02.008_bib97","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jac5.1085","article-title":"Evaluation of dalbavancin on length of stay in acute bacterial skin and skin structure infections","volume":"2","author":"Jones","year":"2019","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.jaip.2026.02.008_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107109","article-title":"Comparative effectiveness and safety of six antibiotics in treating MRSA infections: a network meta-analysis","volume":"146","author":"Ju","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.008_bib99","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.anai.2016.05.017","article-title":"Redesigning the allergy module of the electronic health record","volume":"117","author":"Blumenthal","year":"2016","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:10:27Z","timestamp":1783102227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213219826001455"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining Diagnostic and Management Approaches to Vancomycin Adverse Drug Reactions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}